Ownership

Edward M. MD Kaye - CEO, Director at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: CEO, Director
Stock Symbol: STOK on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Edward M. MD Kaye - trading volume in the past year for Stoke Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-66.5K	100%	$13.37	-$889K
Net	-66.5K	-100%		-$889K

Holdings reported by Edward M. MD Kaye for Stoke Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Restricted Stock Units	105K	$1.66M	$15.78	Mar 27, 2024	Direct	Common Stock
Common Stock	61.9K	$804K	$12.99	Dec 9, 2024	Direct
Performance Stock Units	26.3K	$317K	$12.07	Dec 3, 2024	Direct	Common Stock
Restricted Stock Unit (RSU)	4.32K	$52.1K	$12.07	Dec 1, 2024	Direct	Common Stock
Employee Stock Option (Right to Buy)	159K			Mar 27, 2024	Direct	Common Stock

Transactions reported by Edward M. MD Kaye for Stoke Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.